Sun Pharma to Announce First Quarter Results on July 31, 2026; Earnings Call Scheduled
Sun Pharmaceutical Industries Limited has announced that it will release its results for the first quarter ending June 30, 2026. The company is set to host an earnings call on July 31, 2026.The earnings call, scheduled for 06:30 pm IST on July 31, 2026, will be conducted by the Company's senior management. During the one-hour session, management is expected to discuss the Company’s performance and address questions from participants.
Details regarding participation in the conference call are provided below. The company stated that a transcript of the conference call will also be available on its website.
| Event | Date and Time | Method/Platform |
|---|---|---|
| Earnings release | 31 July 2026 | www.sunpharma.com |
| Earnings conference call | 06:30 pm IST, 31 July 2026 | Universal Number: +91 22 6629 0049, +91 22 7194 5729 via audio webcast (details available on www.sunpharma.com) |
| Pre-registration details | N/A | DiamondPassRegistration |
Sun Pharmaceutical Industries Limited is described as a company with operations spanning five continents and products provided in over 100 countries. The business includes Innovative Medicines, Generics, and Consumer Healthcare products.
SUNPHARMA Stock Price Movement
Sun Pharmaceutical Industries Limited shares edged higher today, closing at ₹1942.6 after gaining 1.22% in the post-market session. The stock finished near its crucial 52-week high amid strong investor interest, with a volume of 2.82 million shares recorded during trading today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.